Medidata Solutions Inc. (MDSO)

70.06
NASDAQ : Technology Services
Prev Close 70.82
Day Low/High 69.10 / 71.47
52 Wk Low/High 59.60 / 88.87
Avg Volume 706.70K
Exchange NASDAQ
Shares Outstanding 59.68M
Market Cap 4.33B
EPS 0.80
P/E Ratio 68.10
Div & Yield N.A. (N.A)
Medidata Honors 2017 Architects Of Hope Award Winners At Medidata NEXT Global

Medidata Honors 2017 Architects Of Hope Award Winners At Medidata NEXT Global

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the winners of the second annual Architects of Hope Awards.

Medidata Introduces New Strategic Monitoring Suite To Ensure Sponsors And Sites Meet ICH E6 Guidelines

Medidata Introduces New Strategic Monitoring Suite To Ensure Sponsors And Sites Meet ICH E6 Guidelines

Sites, Sponsors and CROs are facing increased costs and regulations in the area of monitoring.

Medidata To Host Financial Analyst Day On November 9 In New York City

Medidata To Host Financial Analyst Day On November 9 In New York City

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will host a Financial Analyst Day on Thursday, November 9, 2017 in New York...

Akros Pharma Inc. And Medidata Commemorate 10-year Partnership With Platform Expansion Agreement

Akros Pharma Inc. And Medidata Commemorate 10-year Partnership With Platform Expansion Agreement

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced today that Akros Pharma Inc.

Medidata Reports Record Third Quarter 2017 Results

Medidata Reports Record Third Quarter 2017 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced its financial results for the third quarter of 2017.

Horizon Pharma Plc To Leverage Medidata Clinical Cloud® And ETMF Solutions To Support Its Business Transformation

Horizon Pharma Plc To Leverage Medidata Clinical Cloud® And ETMF Solutions To Support Its Business Transformation

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that Horizon Pharma plc (NASDAQ: HZNP) has selected the Medidata Clinical Cloud®...

Medidata Selected For Inaugural Fortune Future 50 List

Medidata Selected For Inaugural Fortune Future 50 List

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has been selected for the Fortune Future 50 list; a ranking celebrating the...

Medidata Schedules Third Quarter Earnings Conference Call For October 26, 2017

Medidata Schedules Third Quarter Earnings Conference Call For October 26, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its third quarter 2017 financial results before the open of the...

Neurological-Focused Pharmaceutical Company, Lundbeck, Continues Use Of Medidata Clinical Cloud® With Multi-Year Partnership

Neurological-Focused Pharmaceutical Company, Lundbeck, Continues Use Of Medidata Clinical Cloud® With Multi-Year Partnership

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that pharmaceutical firm H.

Industry Leaders Gather At Medidata NEXT Global 2017 To Discuss How Technology Is Transforming Clinical Research

Industry Leaders Gather At Medidata NEXT Global 2017 To Discuss How Technology Is Transforming Clinical Research

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced that Medidata NEXT Global will take place in New York, at Spring Studios from...

Medidata Opens New, Larger London EMEA Headquarters

Medidata Opens New, Larger London EMEA Headquarters

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the official opening of its new EMEA headquarters at 12 Hammersmith Grove, London, to...

Medidata To Present At Citi 2017 Global Technology Conference

Medidata To Present At Citi 2017 Global Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Mike Capone, chief operating officer, and Rouven Bergmann, chief financial...

Medidata's Julie Iskow Honored Among PharmaVOICE 100's Most Inspiring People

Medidata's Julie Iskow Honored Among PharmaVOICE 100's Most Inspiring People

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow, executive vice president and chief technology officer, has...

Fosun Pharma Selects Medidata's Unified Platform For Clinical Development In China

Fosun Pharma Selects Medidata's Unified Platform For Clinical Development In China

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced an enterprise agreement with leading Chinese healthcare group, Shanghai Fosun...

Short Interest In Medidata Solutions Moves 12.8% Lower

Short Interest In Medidata Solutions Moves 12.8% Lower

The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 509,623 share decrease in total short interest for Medidata Solutions, Inc. , to 3,481,339, a decrease of 12.77% since 07/14/2017.

Medidata Earns Recognition As Leading Innovative Company And A Great Place To Work®

Medidata Earns Recognition As Leading Innovative Company And A Great Place To Work®

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has received recognition from two prestigious business publications for its...

Medidata Expands Partnership With BeiGene To Use Medidata's Patient Cloud EPRO Solution

Medidata Expands Partnership With BeiGene To Use Medidata's Patient Cloud EPRO Solution

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that BeiGene, Ltd.

"Nature Reviews Drug Discovery" Publishes New Findings On Trial Complexity Based Upon Benchmark Data From Medidata

"Nature Reviews Drug Discovery" Publishes New Findings On Trial Complexity Based Upon Benchmark Data From Medidata

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, completed an analysis based on nearly 10,000 protocols from Medidata's Pharmaceutical Investigator...

Medidata Reports Record Second Quarter 2017 Results

Medidata Reports Record Second Quarter 2017 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced its financial results for the second quarter of 2017.

Short Interest In Medidata Solutions Falls 11.4%

Short Interest In Medidata Solutions Falls 11.4%

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 482,033 share decrease in total short interest for Medidata Solutions, Inc. , to 3,753,954, a decrease of 11.38% since 06/15/2017.

Medidata Successfully Hosts Annual European NEXT Conference Series

Medidata Successfully Hosts Annual European NEXT Conference Series

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the successful completion of the annual NEXT Conference series in Europe during June...

Worldwide Clinical Trials Selects Medidata To Streamline Clinical Site Reimbursements Across The Globe

Worldwide Clinical Trials Selects Medidata To Streamline Clinical Site Reimbursements Across The Globe

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that after an exhaustive 18 month selection process which encompassed all of the...

Medidata Schedules Second Quarter Earnings Conference Call For July 18, 2017

Medidata Schedules Second Quarter Earnings Conference Call For July 18, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its second quarter 2017 financial results before the open of the...

Chugai Deploys RaveX To Modernize Post-Marketing Surveillance

Chugai Deploys RaveX To Modernize Post-Marketing Surveillance

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that Chugai Pharmaceutical Co.

Theracos More Effectively Manages Both Data And Content With Medidata's ETMF And ETMF Archive Solutions

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that Theracos has expanded its use of the Medidata Clinical Cloud® to include...

InVentiv Health Selects Medidata Enroll®, Medidata's EConsent Platform, To Accelerate Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and inVentiv Health, a leading biopharmaceutical professional services company, today announced...

Median Technologies And Medidata Partner To Deliver Differentiated Image Management Services In Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and Median Technologies (Paris:ALMDT), the Imaging Phenomics Company™, today announced a...

Sponsors And CROs Rely On Analytics In Clinical Research But Are Limited To Traditional And In-House Data, Medidata Finds

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced results of an industry survey to better understand how global life sciences companies...

Chiltern And Medidata Mark 10-Year Anniversary Milestone In Bringing Cloud-based Technology To Clinical Development

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Chiltern, a leading global contract research organization (CRO), today announced an...

UPDATED PRESENTATION DATE: Medidata To Present At Bank Of America Merrill Lynch 2017 Global Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann, chief financial officer, will present at the Bank of America...

TheStreet Quant Rating: B (Buy)